Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCO vs GSK✓SelectedUSD · GSKMCO vs GSK performance historyLatest closeAs of-1.96%11/19
Stock and ETF performance explorer

MCO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+27.1%
GSK return
+39.6%
Excess return
-12.5%
Maximum drawdown
-40.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.4%-1.6%
7D-6.9%-4.7%-2.1%-5.9%
30D-0.7%-4.7%+4.0%+0.3%
3M-5.1%-8.8%+3.7%-3.3%
6M+8.8%-4.6%+13.5%+9.7%
YTD-7.0%+1.0%-8.0%-8.2%
1Y+0.6%+6.9%-6.2%-2.0%
3Y+35.5%+52.5%-17.0%+16.7%
5Y+27.1%+40.3%-13.2%+4.7%
All+27.1%+39.6%-12.5%+4.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling